Cruz AO

Language: Spanish
References: 21
Page: 739-744
PDF size: 181.99 Kb.

ABSTRACT

Cerebral venous thrombosis is an uncommon clinical entity. The key to the diagnosis is maintaining a high degree of clinical suspicion and radiological confirmation. Anticoagulation is reasonable even in the presence of hemorrhagic infarction. Cerebral venous thrombosis can cause devastating injury to the brain, but most patients have a good prognosis if it is recognized and treated early.

REFERENCES

1. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999;53(7):1537Y1542.

2. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6(2):162Y170.

3. Canhão P, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36(8):1720–1725

4. Coutinho JM et al. The incidence of cerebral venous thrombosis A cross – sectional study. Stroke. 2012;43:3375-3377

5. Coutinho JM, Ferro JM, Zuurbier SM, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke 2013;8(2):135Y140.

6. Einha ̈upl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13:553–559.

7. Ferro J, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35(3):664Y670.

8. Ferro JM, Correia M, Rosas MJ, Pinto AN, Neves G. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2003;15:78—83.

9. Ferro JM, Lopes MG, Rosas MJ, et al. Long – term Prognosis of Cerebral Vein and Dural Sinus Thrombosis. Results of the venoport study. Cerebrovasc Dis. 2002;13(4):272 – 278.

10. Girot M, Ferro JM, Canhåo P, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007;38(2):337Y342.

11. Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, et al., ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke. 2007;38:337—42.

12. Grover M. Cerebral venous thrombosis as a cause of acute headache. J Am Board Fam Pract. 2004;17:295 – 298.

13. Guenther G, Arauz A. Trombosis venosa cerebral: aspectos actuales del diagnostico y tratatamiento. Neurologia. 2011;26:488 – 498

14. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H. MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images. Stroke. 2006;37:991—5.

15. Kosinski CM, Mull M, Schwarz M, et al. Do normal D – dimer levels reliably exclude cerebral sinus thrombosis?. Stroke. 2004;35(12):2820 – 2825.

16. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. N Engl J Med 1998;338: 1793-7.

17. Masuhr F, Einhäupl K. Treatment of cerebral venous and sinus thrombosis. Front Neurol Neurosci. 2008;23:132—43.

18. Puig J, Pedraza S, Blasco G, Serena J. Actualizacion en el diagnostico neuroradiologico de la trombosis venosa cerebral. Radiologia. 2009;51:351 – 361

19. Saposnik G, Barinagarrementeria F, Brown R, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2011;42(4):1158Y1192.

20. Sasidharan PK. Cerebral vein thrombosis misdiagnosed and mismanaged. Thrombosis. 2012;2012:210676.

21. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352(17): 1791Y1798.